Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Biomaterials. 2019 Apr 12;209:79–87. doi: 10.1016/j.biomaterials.2019.04.020

Figure 6.

Figure 6.

PBAE nanoparticle co-delivery of five siRNAs reduced tumor growth in an orthotopic model of human GBM. Hemotoxylin- and eosin-stained histological slides of siRNA treated tumors (A) show reduced tumor burden versus (B) scRNA treated tumors. (C) IVIS tracking of luciferase-positive GBM tumors shows inhibited tumor growth in siRNA-treated tumors. (D) Quantification of siRNA-mediated reduction in tumor burden (n = 3 per group). Scale bar = 2 mm.